MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells

Abstract Natural killer group 2 member D ligands (NKG2DLs) are expressed as stress response proteins in cancer cells. NKG2DLs induce immune cell activation or tumor escape responses, depending on their expression. Human pancreatic cancer cells, PANC-1, express membrane MHC class I polypeptide-relate...

Full description

Bibliographic Details
Published in:Scientific Reports
Main Authors: Hitoshi Toyoda, Atsuo Kuramasu, Masahiro Hosonuma, Masakazu Murayama, Yoichiro Narikawa, Junya Isobe, Yuta Baba, Kohei Tajima, Eiji Funayama, Midori Shida, Yuki Maruyama, Aya Sasaki, Yuya Hirasawa, Toshiaki Tsurui, Hirotsugu Ariizumi, Tomoyuki Ishiguro, Risako Suzuki, Sei Kobayashi, Atsushi Horiike, Noriko Hida, Takehiko Sambe, Koji Nobe, Satoshi Wada, Hitome Kobayashi, Mayumi Tsuji, Shinichi Kobayashi, Takuya Tsunoda, Yoshifumi Kudo, Yuji Kiuchi, Kiyoshi Yoshimura
Format: Article
Language:English
Published: Nature Portfolio 2024-10-01
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-73712-1
_version_ 1850351790455783424
author Hitoshi Toyoda
Atsuo Kuramasu
Masahiro Hosonuma
Masakazu Murayama
Yoichiro Narikawa
Junya Isobe
Yuta Baba
Kohei Tajima
Eiji Funayama
Midori Shida
Yuki Maruyama
Aya Sasaki
Yuya Hirasawa
Toshiaki Tsurui
Hirotsugu Ariizumi
Tomoyuki Ishiguro
Risako Suzuki
Sei Kobayashi
Atsushi Horiike
Noriko Hida
Takehiko Sambe
Koji Nobe
Satoshi Wada
Hitome Kobayashi
Mayumi Tsuji
Shinichi Kobayashi
Takuya Tsunoda
Yoshifumi Kudo
Yuji Kiuchi
Kiyoshi Yoshimura
author_facet Hitoshi Toyoda
Atsuo Kuramasu
Masahiro Hosonuma
Masakazu Murayama
Yoichiro Narikawa
Junya Isobe
Yuta Baba
Kohei Tajima
Eiji Funayama
Midori Shida
Yuki Maruyama
Aya Sasaki
Yuya Hirasawa
Toshiaki Tsurui
Hirotsugu Ariizumi
Tomoyuki Ishiguro
Risako Suzuki
Sei Kobayashi
Atsushi Horiike
Noriko Hida
Takehiko Sambe
Koji Nobe
Satoshi Wada
Hitome Kobayashi
Mayumi Tsuji
Shinichi Kobayashi
Takuya Tsunoda
Yoshifumi Kudo
Yuji Kiuchi
Kiyoshi Yoshimura
author_sort Hitoshi Toyoda
collection DOAJ
container_title Scientific Reports
description Abstract Natural killer group 2 member D ligands (NKG2DLs) are expressed as stress response proteins in cancer cells. NKG2DLs induce immune cell activation or tumor escape responses, depending on their expression. Human pancreatic cancer cells, PANC-1, express membrane MHC class I polypeptide-related sequence A/B (mMICA/B), whereas soluble MICB (sMICB) is detected in the culture supernatant. We hypothesized that sMICB saturates NKG2D in NKG2DLow T cells and inhibits the activation signal from mMICB to NKG2D. Knockdown of MICB by siRNA reduced sMICB level, downregulated mMICB expression, maintained NKG2DLow T cell activation, and inhibited NKG2DHigh T cell activation. To maintain mMICB expression and downregulate sMICB expression, we inhibited a disintegrin and metalloproteinase (ADAM), a metalloproteinase that sheds MICB. Subsequently, the shedding of MICB was prevented using ADAM17 inhibitors, and the activation of NKG2DLow T cells was maintained. In vivo xenograft model revealed that NKG2DHigh T cells have superior anti-tumor activity. These results elucidate the mechanism of immune escape via sMICB and show potential for the activation of NKG2DLow T cells within the tumor microenvironment.
format Article
id doaj-art-9cc18d13b98e4eae855bec63d4c5642c
institution Directory of Open Access Journals
issn 2045-2322
language English
publishDate 2024-10-01
publisher Nature Portfolio
record_format Article
spelling doaj-art-9cc18d13b98e4eae855bec63d4c5642c2025-08-19T23:09:11ZengNature PortfolioScientific Reports2045-23222024-10-0114111210.1038/s41598-024-73712-1MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cellsHitoshi Toyoda0Atsuo Kuramasu1Masahiro Hosonuma2Masakazu Murayama3Yoichiro Narikawa4Junya Isobe5Yuta Baba6Kohei Tajima7Eiji Funayama8Midori Shida9Yuki Maruyama10Aya Sasaki11Yuya Hirasawa12Toshiaki Tsurui13Hirotsugu Ariizumi14Tomoyuki Ishiguro15Risako Suzuki16Sei Kobayashi17Atsushi Horiike18Noriko Hida19Takehiko Sambe20Koji Nobe21Satoshi Wada22Hitome Kobayashi23Mayumi Tsuji24Shinichi Kobayashi25Takuya Tsunoda26Yoshifumi Kudo27Yuji Kiuchi28Kiyoshi Yoshimura29Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Hospital Pharmaceutics, Showa University School of PharmacyDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDivision of Medical Oncology, Department of Medicine, Showa University School of MedicineDivision of Medical Oncology, Department of Medicine, Showa University School of MedicineDivision of Medical Oncology, Department of Medicine, Showa University School of MedicineDivision of Medical Oncology, Department of Medicine, Showa University School of MedicineDivision of Medical Oncology, Department of Medicine, Showa University School of MedicineDepartment of Otorhinolaryngology, Showa University School of MedicineDivision of Medical Oncology, Department of Medicine, Showa University School of MedicineDivision of Clinical Pharmacology, Department of Pharmacology, Showa University School of MedicineDivision of Clinical Research and Development, Department of Clinical Pharmacy, School of Pharmacy, Showa UniversityPharmacological Research Center, Showa UniversityDepartment of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDepartment of Otorhinolaryngology, Showa University School of MedicinePharmacological Research Center, Showa UniversityClinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityDivision of Medical Oncology, Department of Medicine, Showa University School of MedicineDepartment of Orthopedic Surgery, Showa University School of MedicineDepartment of Pharmacology, Showa University School of MedicineDepartment of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa UniversityAbstract Natural killer group 2 member D ligands (NKG2DLs) are expressed as stress response proteins in cancer cells. NKG2DLs induce immune cell activation or tumor escape responses, depending on their expression. Human pancreatic cancer cells, PANC-1, express membrane MHC class I polypeptide-related sequence A/B (mMICA/B), whereas soluble MICB (sMICB) is detected in the culture supernatant. We hypothesized that sMICB saturates NKG2D in NKG2DLow T cells and inhibits the activation signal from mMICB to NKG2D. Knockdown of MICB by siRNA reduced sMICB level, downregulated mMICB expression, maintained NKG2DLow T cell activation, and inhibited NKG2DHigh T cell activation. To maintain mMICB expression and downregulate sMICB expression, we inhibited a disintegrin and metalloproteinase (ADAM), a metalloproteinase that sheds MICB. Subsequently, the shedding of MICB was prevented using ADAM17 inhibitors, and the activation of NKG2DLow T cells was maintained. In vivo xenograft model revealed that NKG2DHigh T cells have superior anti-tumor activity. These results elucidate the mechanism of immune escape via sMICB and show potential for the activation of NKG2DLow T cells within the tumor microenvironment.https://doi.org/10.1038/s41598-024-73712-1NKG2DLNKG2DT cellMICBADAMPancreatic tumor
spellingShingle Hitoshi Toyoda
Atsuo Kuramasu
Masahiro Hosonuma
Masakazu Murayama
Yoichiro Narikawa
Junya Isobe
Yuta Baba
Kohei Tajima
Eiji Funayama
Midori Shida
Yuki Maruyama
Aya Sasaki
Yuya Hirasawa
Toshiaki Tsurui
Hirotsugu Ariizumi
Tomoyuki Ishiguro
Risako Suzuki
Sei Kobayashi
Atsushi Horiike
Noriko Hida
Takehiko Sambe
Koji Nobe
Satoshi Wada
Hitome Kobayashi
Mayumi Tsuji
Shinichi Kobayashi
Takuya Tsunoda
Yoshifumi Kudo
Yuji Kiuchi
Kiyoshi Yoshimura
MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells
NKG2DL
NKG2D
T cell
MICB
ADAM
Pancreatic tumor
title MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells
title_full MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells
title_fullStr MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells
title_full_unstemmed MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells
title_short MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells
title_sort mhc class i polypeptide related sequence b shedding modulates pancreatic tumor immunity via the activation of nkg2dlow t cells
topic NKG2DL
NKG2D
T cell
MICB
ADAM
Pancreatic tumor
url https://doi.org/10.1038/s41598-024-73712-1
work_keys_str_mv AT hitoshitoyoda mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT atsuokuramasu mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT masahirohosonuma mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT masakazumurayama mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT yoichironarikawa mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT junyaisobe mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT yutababa mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT koheitajima mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT eijifunayama mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT midorishida mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT yukimaruyama mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT ayasasaki mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT yuyahirasawa mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT toshiakitsurui mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT hirotsuguariizumi mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT tomoyukiishiguro mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT risakosuzuki mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT seikobayashi mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT atsushihoriike mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT norikohida mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT takehikosambe mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT kojinobe mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT satoshiwada mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT hitomekobayashi mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT mayumitsuji mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT shinichikobayashi mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT takuyatsunoda mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT yoshifumikudo mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT yujikiuchi mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells
AT kiyoshiyoshimura mhcclassipolypeptiderelatedsequencebsheddingmodulatespancreatictumorimmunityviatheactivationofnkg2dlowtcells